Co-expression of Parathyroid Hormone and Chromogranin Ain Secondary Hyperparathyroidism: A Functional Marker for Secretory Activity of Hyperplastic Nodules
Source: Pathology Research and Practice, Volume 199, Number 2, April 2003 , pp. 93-99(7)
Publisher: Urban & Fischer
The relationship between secretion of parathyroid hormone (PTH) and biologic characteristics, including cell proliferation or monoclonality, is not yet fully understood. To evaluate secretory activity of glands or nodules histopathologically, we focused on the co-expression of chromogranin A(CgA) and parathyroid hormone (PTH) in each gland or nodule. Atotal of 55 glands from 38 patients with normal parathyroid glands, hyperplastic glands (diffuse and nodular) and primary adenomas were compared. Co-expression of PTH and CgA was decreased to 44.4% in diffuse hyperplastic glands, and to 39.6% in 91 hyperplastic nodules, in contrast to normal glands and primary adenomas that showed constant co-expression of PTH and CgA. Immunohistochemical study of PTH showed a coarse granular pattern predominantly in PTH-positive/CgA-positive nodules, and a dot-like pattern mainly in PTH-positive/CgA-negative nodules. Laser scanning microscopy and immunoelectron microscopy confirmed that a dot-like pattern is based on a positive reaction of PTH at the Golgi apparatus. MIB-1 LI was 12.6 ± 11.6 in PTH-positive/CgA-positive, and 19.3 ± 27.3 in PTH-positive/CgA-negative nodules. In conclusion, a combination of PTH and CgAcould provide more information about the physiologic state of secretory activity of each nodule than does the simple observation of PTH immunoreactivity.
Document Type: Original article
Affiliations: 1: Division of Nephrology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan 2: Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan
Publication date: 2003-04-01